Clinical Trials Logo
  1. Home
  2. Low Bone Mineral Density
  3. NCT00325468

An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density

Low Bone Mineral Density Clinical Trial

Official title:
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density

Clinical Trial Summary

An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women with Low Bone Mineral Density

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00325468
Study type Interventional
Source Amgen
Contact
Status Completed
Phase Phase 3
Start date May 2006
Completion date August 2012
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05902078 - Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis Phase 4
Completed NCT00980174 - Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis Phase 3
Completed NCT00089661 - AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer Phase 3
Completed NCT00925600 - A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy Phase 3
Completed NCT00515463 - A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density Phase 3
Completed NCT00043186 - Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density Phase 2
Completed NCT00896532 - Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density Phase 2
Completed NCT00887965 - A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab Phase 2
Completed NCT00890981 - A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab Phase 3
Completed NCT01215890 - Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease Phase 4